Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID-19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series

https://doi.org/10.1186/s12985-020-01428-5

In the retrospective COVID-19 cohort, gender was one of the important factors affecting patient’s conditions. Arbidol showed several beneficial effects in these patients, especially in males. Basically, males had a higher risk of fever and more onset symptoms than females. Arbidol could accelerate fever recovery and viral clearance in respiratory specimens, particularly in males. Arbidol also contributed to shorter hospital stay without obvious adverse reactions.